Pathologic examination should distinguish primary or metastatic pheochromocytomas and paragangliomas from other endocrine or nonendocrine tumors and flag tumors with features suggestive of ...

or metastatic pheochromocytoma and paraganglioma (PPGL). According to Merck, the application was accepted based on objective response rate (primary endpoint; as assessed by blinded independent central ...

AZEDRA is indicated for the treatment of adult and pediatric patients 12 years and older with iobenguane scan positive, unresectable, locally advanced or metastatic pheochromocytoma or ...

Priority review for Welireg is based on data from the Phase II LITESPARK-015 trial, which showed promising response rates in patients with advanced, unresectable, or metastatic pheochromocytoma and ...

The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma.

Signs and symptoms of adrenal insufficiency include: Sometimes adrenal nodules show up on an imaging scan (CT scan or MRI ... possible excess hormone production or suspicion of cancer. A ...

The First International Symposium on Pheochromocytoma ... Inadequate methods to distinguish malignant from benign tumors and a lack of effective treatments for malignancy are important problems ...